- Published on:
Havana, Dec 17 (Prensa Latina) Cuba is conducting two clinical trials on chikungunya patients to demonstrate the safety and therapeutic effect of subcutaneous administration of the drug Jusvinza in patients in the post-acute and chronic phases, it was announced.







